1. Clinical and operational impact of rapid point-of-care SARS-CoV-2 detection in an emergency department
- Author
-
Camille Gerlier, Benoit Pilmis, Alban Le Monnier, Jean-Claude Nguyen Van, and Olivier Ganansia
- Subjects
Male ,medicine.medical_specialty ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,IDNOW COVID-19 ,Isothermal nucleic acid amplification technology ,Article ,Cohort Studies ,COVID-19 Testing ,Clinical pathway ,Ambulatory care ,Operational impact ,Humans ,Medicine ,NAAT ,Aged ,Point of care ,Aged, 80 and over ,Emergency department ,SARS-CoV-2 ,business.industry ,Mortality rate ,Nicking enzyme amplification reaction technology ,COVID-19 ,Cilnical impact ,General Medicine ,Middle Aged ,Hospitalization ,Controlled Before-After Studies ,Point-of-Care Testing ,Point-of-care ,Emergency medicine ,Emergency Medicine ,Female ,Observational study ,Emergency Service, Hospital ,business - Abstract
Study objective Rapid point-of-care (POC) SARS-CoV-2 detection with Abbott ID NOW™ COVID-19 test has been implemented in our Emergency Department (ED) for several months. We aimed to evaluate the operational impact and potential benefits of this innovative clinical pathway. Methods We conducted a prospective, descriptive, interventional, non-randomized study, before-after trial with the comparison of patient cohorts from two consecutive periods of seven weeks (observational pre-POC period vs interventional POC period). Results In 2020, throughout weeks 37 to 50, 3333 patients were assessed for eligibility and among them 331 (9.9%) were positive for SARS-CoV-2 infections. Among the included patients, 136 (9.2%) were positive for SARS-CoV-2 infection in the pre-POC period and 195 (10.5%) in the POC period. Among positive patients for SARS-CoV-2 related infection in-hospital mortality rate was similar between the two groups but the hospitalization rate was higher in the POC group (81.6% vs. 65.4%; p
- Published
- 2021